鼻出血与动脉粥样硬化性心血管疾病的关联
苏黎世大学医院耳鼻咽喉科2016年12月1日至2017年6月1日的病例对照队列研究,纳入41例鼻出血患者与41例匹配对照,比较颈动脉内膜中层厚度等指标;鼻出血组颈动脉内膜中层厚度均值较对照高26%,严重鼻出血与更低踝臂指数及更高QRISK2相对风险相关,校正混杂后颈动脉内膜中层厚度每增加0.1 mm鼻出血比值比为2.5。
要点
- 鼻出血患者颈动脉内膜中层厚度均值较对照高26%(1.06 mm vs 0.84 mm,P < .001)。
- 严重鼻出血与更低踝臂指数相关(0.96 vs 1.05,P < .001)。
- 严重鼻出血组QRISK2相对风险高于对照(1.81 vs 1.35,P = .028)。
核心结论
- 严重鼻出血的发生与动脉粥样硬化性心血管疾病患病率密切相关。
- 作者认为鼻出血患者应被视为心血管风险升高人群,提示需要适当的进一步医学评估和预防措施。
研究设计与样本
- 病例对照队列研究,纳入苏黎世大学医院耳鼻咽喉科2016年12月1日至2017年6月1日患者。
- 鼻出血组41例与匹配对照41例,评估心血管风险特征,重点为颈动脉内膜中层厚度这一动脉粥样硬化替代指标。
- 证据等级3b,临床试验注册号NCT03092973。
主要发现
- 鼻出血组颈动脉内膜中层厚度均值1.06 mm(SD = 0.17),较对照组均值0.84 mm(SD = 0.14)平均高26%(P < .001)。
- 严重鼻出血与更低踝臂指数相关:0.96(SD = 0.12)vs 1.05(SD = 0.17)(P < .001)。
- 严重鼻出血组QRISK2相对风险高于对照组:1.81(SD = 0.97)vs 1.35(SD = 0.28)(P = .028)。
- 校正可能混杂因素的二元逻辑回归模型显示,研究人群中颈动脉内膜中层厚度每增加0.1 mm,鼻出血发生的比值比为2.5(95%CI:1.56-4.11;P < .001)。
临床怎么用
- 作者认为鼻出血患者应被视为心血管风险升高人群,提示需要适当的进一步医学评估和预防措施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To investigate the association between epistaxis and atherosclerotic cardiovascular disease. STUDY DESIGN: Case-control cohort study. METHODS: This study included patients from the tertiary-care ear, nose, and throat department at the University Hospital of Zurich between December 1, 2016 and June 1, 2017. We assessed the cardiovascular risk profiles in a group of 41 patients presenting with epistaxis, and a group of 41 matched controls, focusing on a surrogate parameter for atherosclerosis: the carotid intima-media thickness (CIMT). RESULTS: With a mean of 1.06 mm (standard deviation [SD] = 0.17), CIMT values were on average 26% higher in epistaxis patients than in their controls, with a mean of 0.84 mm (SD = 0.14; P < .001). Occurrence of severe epistaxis was also associated with lower ankle-brachial index values at 0.96 (SD = 0.12) versus 1.05 (SD = 0.17) (P < .001) and significantly higher QRISK2 relative risks (an algorithm for predicting cardiovascular risk) than found in the control group (1.81, SD = 0.97 vs. 1.35, SD = 0.28; P = .028). A binary logistic regression model, adjusted for possible confounders, showed an odds ratio of 2.5 for the occurrence of epistaxis per increase in CIMT of 0.1 mm in the study population (95% confidence interval: 1.56-4.11; P < .001). CONCLUSIONS: The occurrence of severe epistaxis was shown to be closely associated with the prevalence of atherosclerotic cardiovascular disease. Accordingly, patients affected by epistaxis should be regarded as at an elevated cardiovascular risk, which indicates the need for appropriate further medical assessment and preventive measures. LEVEL OF EVIDENCE: 3b TRIAL REGISTRATION: Clinical trials NCT03092973 Laryngoscope, 129:783-787, 2019.
引用
- Kunz SM, Holzmann D, Soyka MB, et al. Association of epistaxis with atherosclerotic cardiovascular disease. Laryngoscope. 2018. PMID: 30549051. doi:10.1002/lary.27604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。